Table of Contents (Version-2026)
Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Formulation
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Porter’s Analysis
- Industry Trends
- Key Highlights
- Epidemiology
- Reimbursement Scenario
- Regulatory Scenario
- Product Launch and Approvals
- Acquisition and Collaboration Scenario
- Market Dynamics
U.S. Intravenous Immunoglobulin Market - Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Impact of COVID-19 on Demand and Supply of Intravenous Immunoglobulin
- Impact of COVID-19 on the overall Healthcare Sector
U.S. Intravenous Immunoglobulin Market, By Formulation, 2017 - 2028 (US$ Billion)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 - 2028
- Segment Trends
- Liquid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
- Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
- Introduction
U.S. Intravenous Immunoglobulin Market, By Application, 2017 - 2028 (US$ Billion)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 - 2028
- Segment Trends
- Hypogammaglobulinemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
- Primary Immunodeficiency Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
- Myasthenia Gravis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
- Multifocal Motor Neuropathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
- Kawasaki Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
- Introduction
U.S. Intravenous Immunoglobulin Market, By Distribution Channel, 2017 - 2028 (US$ Billion)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 - 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
- Introduction
Competitive Landscape
- Company Profiles
- Biotest AG *
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Octapharma AG
- Grifols S.A.
- Kedrion Biopharma, Inc.
- CSL Behring
- McKesson Corporation
- Takeda Pharmaceutical Company Limited
- Bio Products Laboratory Ltd.
- Pfizer, Inc.
- ADMA Biologics, Inc.
- Biotest AG *
- Company Profiles
*Key pointers provided are also applicable to other companies covered in the scope of the report.
Section
- Research Methodology
- About us
- Contact
*Browse 33 market data tables and 25 figures on “Intravenous Immunoglobulin Market” – U.S. Forecast to 2028.
EXISTING CLIENTELE
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients


